Transforming Gut Microbiome Science into Life-Changing Diagnostic and Therapeutic Solutions.

Transforming Gut Microbiome Science into Life-Changing Diagnostic and Therapeutic Solutions

Our Solutions

First in class evidence-based solutions to treat and prevent human disease by diagnosing and treating dysbiosis.

Generating data to develop microbiome-based interventions.

I will prevent disease whenever I can, for prevention is preferable to cure.

– Physicians’ Hippocratic Oath

Dr. Chang on gray background with teal border

32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics

January 8, 2026

32 Biosciences Set to Attend the 2026 JPM Healthcare Conference

December 31, 2025

32 Biosciences Joins Featured Startups in the Midwest Biotech Startup Showcase

December 31, 2025